Phase 1 data confirms SAB-142 does not cause serum sickness and has low/no immunogenicity at any dose and in all cohorts, ...

SAB BIO has announced a $175 million private placement financing to fund its pivotal Phase 2b SAFEGUARD study of SAB-142, aimed at delaying the progression of autoimmune type 1 diabetes (T1D) in newly ...

Joint presentation by Orchestra BioMed and Medtronic leadership to discuss ongoing strategic collaboration for development and commercialization ...

The State Audit Bureau is currently reviewing 24 tenders and projects planned for Kuwait International Airport, with a total ...

Enrollment in the SAFEGUARD trial is ongoing at multiple centers globallyCompany on-track to share Phase 2b data in 2H 2027 ...

MIAMI, Jan. 28, 2025 (GLOBE NEWSWIRE) -- SAB BIO (Nasdaq: SABS), (“SAB BIO” or the “Company”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that is developing human ...

The Staff Accounting Bulletin (SAB) 121 rule was introduced by the SEC in March 2022 as part of its efforts to regulate cryptocurrency custody. It required financial institutions to list any crypto ...

SAB has launched a new, more modern logo. Its CEO believes better times lie ahead for South Africa thanks to a growing youthful population. A merged Heineken and Distell group could bring more ...

SAB’s 9M 2025 net profit rises to SAR 6.41B; Q3 at SAR 2.14B 9 M 2025 SAB profit up 5% to SAR 4.3B in H1 2025; Q2 at SAR 2.1B 6 M 2025 SAB profit rises 5% to SAR 2.13B in Q1 2025 3 M 2025 SAB's 2024 ...

Sab Zada and Jaden Smith seemingly split in August 2024 Charlotte Walsh is an evergreen editor at PEOPLE. She has been contributing to PEOPLE since 2022. Her work has previously appeared in Women's ...